Republican senators on Sunday voted down a cap on the price tag on insulin in the private market, removing it from Democrats’ sweeping climate and economic package.
Democrats had tried to preserve the provision to cap insulin costs at $35 for private insurers, but that vote failed 57-43, with seven Republicans voting using them to help keep the insulin cost cap in the bill, three lacking that which was needed.
The move was expected carrying out a decision by the Senate parliamentarian, who determined earlier that the insulin provision had not been compliant with the chamber’s strict budget rules. Democrats have to adhere to those rules to advance the legislation, called the Inflation Reduction Act, without the Republican votes.
The legislation, however, still carries a $35 copay cap on the price tag on insulin for folks 65 and older on Medicare.
Following vote, Senate Finance Committee Chair Ron Wyden, D-Ore., accused Republicans of caving to pressures from the pharmaceutical industry at the trouble of citizens.
Republicans have just gone on the record and only expensive insulin, Wyden said in a statement. After years of tough discuss dealing with insulin makers, Republicans have once against wilted when confronted with heat from Big Pharma.”
“Fortunately, the $35 insulin copay cap for insulin in Medicare remains in the bill, so seniors are certain to get rest from high insulin costs. I’ll continue attempting to deliver lower insulin costs to all or any Americans,” he added.
Republican Sens. Bill Cassidy and John Kennedy of Louisiana; Susan Collins of Maine; Josh Hawley of Missouri; Cindy Hyde-Smith of Mississippi; and Lisa Murkowski and Dan Sullivan of Alaska joined Democrats in voting to help keep the insulin cap for private insurers on Sunday.
Senators have already been working through the weekend on amendment votes following the chamber advanced the bill Saturday in a 51-50 procedural vote, with all Republicans opposing the motion to proceed with the bill and Vice President Kamala Harris casting the tie-breaking vote.
Senate Democrats are looking to pass the legislation on Sunday, bringing long-stalled components of President Joe Bidens agenda, including major spending to combat climate change and extend healthcare coverage, one step nearer to reality. The package will head to the home, that is currently likely to vote onto it on Friday.
Frank Thorp V